Antiparasitic Resistance — A Growing Threat to Global Health
Dr.Priyanka1, Dr.Sarjna Meena2,Dr. Anikta Kumari3,Dr.Jyoti Pahariya3
Department of Veterinary Parasitology
Post Graduate Institute of Veterinary Education and Research, Jaipur
RUVAS,Jobner
Introduction
Parasitic infections affect millions of people and animals worldwide. From malaria and schistosomiasis in humans to heartworm in dogs and livestock infections, parasites have shaped human history and health. For decades, antiparasitic drugs have helped control these infections. However, a new challenge has emerged: antiparasitic resistance — when parasites evolve and no longer respond effectively to medicines once used to control them.
Antiparasitic resistance threatens public health, food security, and animal welfare. This article explores what antiparasitic resistance is, why it is rising, and what solutions science and society are pursuing.
What Is Antiparasitic Resistance?
Antiparasitic resistance occurs when parasites such as protozoa, helminths (worms), or ectoparasites (like ticks) develop the ability to survive treatments that once killed them. This phenomenon is similar to antibiotic resistance in bacteria but occurs in a wide range of organisms, including:
Malaria parasites (Plasmodium spp.)
Leishmania species
Schistosoma species
Helminths like Haemonchus contortus (a problematic parasite in sheep)
Ticks and mites
Resistance arises through genetic changes in the parasite that reduce the drug’s effectiveness.
Why Is Resistance Growing?
1. Overuse and Misuse of Drugs
Using antiparasitic medicines too frequently, in incorrect doses, or without proper diagnosis accelerates resistance. For example:
In regions where antimalarials are widely used without confirmed diagnosis, resistant malaria strains have emerged.
In livestock farming, routine use of dewormers without rotation or targeted treatment leads to resistant worm populations.
2. Genetic Adaptation by Parasites
Parasites reproduce quickly and with large populations, providing many opportunities for random mutations. When a parasite survives a drug dose due to a mutation, it can pass that trait to offspring, gradually making the population resistant.
3. Environmental and Climate Factors
Warmer temperatures and changing ecosystems allow some parasites and their vectors (like mosquitoes and ticks) to expand into new regions, increasing disease burden and drug use — further driving resistance.
Examples of Alarming Resistance Cases
Malaria Resistance
Malaria, caused by Plasmodium falciparum, has shown resistance to several mainstay drugs, including chloroquine and sulfadoxine–pyrimethamine. Even newer drugs like artemisinin derivatives face decreased effectiveness in parts of Southeast Asia.
Helminth Resistance in Livestock
In sheep and cattle farming, resistance to commonly used dewormers such as benzimidazoles and macrocyclic lactones is widespread. In some farms, these drugs now fail to reduce parasite burdens at all.
Leishmania and Trypanosoma
Leishmaniasis and sleeping sickness parasites have shown resistance to older treatments like pentavalent antimonials and, increasingly, to amphotericin B and miltefosine in some regions.
Consequences of Resistance
Antiparasitic resistance affects multiple areas:
Human health: Harder-to-treat infections increase illness, disability, and death.
Animal health: Livestock losses from drug-resistant parasites hurt farmers’ livelihoods.
Economics: Increased healthcare and veterinary costs burden families and nations.
Ecosystems: Resistant parasites can spread to new areas, affecting wildlife and biodiversity.
Solutions and What Can Be Done
1. Responsible Drug Use
Use antiparasitics only when necessary and based on proper diagnosis.
Follow correct dosages and treatment duration.
2. Drug Rotation and Combination Therapy
Alternating drugs with different modes of action can slow resistance. Combining drugs can reduce the chance that parasites survive treatment.
3. Surveillance and Research
Monitoring resistance patterns worldwide helps scientists and policymakers respond early. New diagnostics and faster detection tools are essential.
4. New Drug Development
Investing in research to discover new antiparasitic medicines and vaccines is critical to stay ahead of evolving parasites.
5. Integrated Control Measures
Using non-drug approaches such as improved sanitation, vector control (e.g., mosquito nets), animal husbandry practices, and public health education can reduce reliance on medications.
Conclusion
Antiparasitic resistance is an urgent global problem. Parasites are adapting faster than new drugs are being developed, risking a future where common infections become untreatable. Coordinated efforts in research, surveillance, drug stewardship, and public health interventions are crucial to protect human and animal health.
References
Turner, J.D. et al. Anthelmintic resistance in livestock parasites. Nature Reviews Microbiology, 2020.
Kaplan, R.M., Drug resistance in nematodes of veterinary importance: A status report. Trends in Parasitology, 2004.
World Health Organization (WHO). World Malaria Report 2020. WHO Press, 2020.
McDermott, J.J. et al. Climate change and parasitic infection risks. Global Health Journal, 2018.
Verma, S. et al. Emerging antiparasitic resistance in Leishmania. Clinical Microbiology Reviews, 2019.



